These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 10558596)
41. FDA approves generic AZT for U.S. market. O'Rourke M AIDS Clin Care; 2005 Nov; 17(11):108. PubMed ID: 16323302 [No Abstract] [Full Text] [Related]
42. Microcap pharmaceutical firms: linking drug pipelines to market value. Beach R J Health Care Finance; 2012; 39(2):82-92. PubMed ID: 23971143 [TBL] [Abstract][Full Text] [Related]
43. The changing environment for technological innovation in health care. Goodman CS; Gelijns AC Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263 [TBL] [Abstract][Full Text] [Related]
44. A precarious balancing act--the role of the FDA as protector of public health and industry wealth. McCabe AR Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844 [No Abstract] [Full Text] [Related]
45. When medicine becomes a disease. Arabia; 1986 Mar; 5(55):32-6. PubMed ID: 12340711 [TBL] [Abstract][Full Text] [Related]
48. Price regulation and generic competition in the pharmaceutical market. Dalen DM; Strøm S; Haabeth T Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230 [TBL] [Abstract][Full Text] [Related]
49. SuperGenerics: a better alternative for biogenerics. Charles SA Drug Discov Today; 2005 Apr; 10(8):533-5. PubMed ID: 15837591 [No Abstract] [Full Text] [Related]
53. Patent infringement. Generic HIV drugmaker's patent claim is time-barred. AIDS Policy Law; 2003 Aug; 18(16):6. PubMed ID: 14626916 [No Abstract] [Full Text] [Related]
54. Strategies for acquiring affordable medications for seniors. Morris KJ Nurs Clin North Am; 2005 Mar; 40(1):51-62, vi. PubMed ID: 15733946 [TBL] [Abstract][Full Text] [Related]
55. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification. Smart A; Martin P Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196 [TBL] [Abstract][Full Text] [Related]
56. FDA notifications. Tentative approval of India-made zidovudine. AIDS Alert; 2005 Sep; 20(9):108. PubMed ID: 16206404 [No Abstract] [Full Text] [Related]
57. The Drug Price Competition and Patent Term Restoration Act of 1984: fine-tuning the balance between the interests of pioneer and generic drug manufacturers. Soehnge H Food Drug Law J; 2003; 58(1):51-80. PubMed ID: 12739584 [No Abstract] [Full Text] [Related]
58. WHO pulls Indian generics off AIDS drugs list. Nat Med; 2004 Sep; 10(9):885. PubMed ID: 15340402 [No Abstract] [Full Text] [Related]
59. Sandoz sues FDA over delay in first biogeneric approval. Fox JL Nat Biotechnol; 2005 Nov; 23(11):1327-8. PubMed ID: 16273046 [No Abstract] [Full Text] [Related]
60. Impact of generic drug entry on cost-effectiveness analysis. Shih YC; Han S; Cantor SB Med Decis Making; 2005; 25(1):71-80. PubMed ID: 15673583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]